EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische Studie

Safety and Efficacy of Intravascular Lithotripsy System: A Prospective, Multicenter Clinical Trial (The VIGOUR Study)

Tao Chen, Jiawei Zhao, Yong He, Chao Fang, Xuebin Han, Bo Luan, Yan Wang, Manhua Chen, Zuyi Yuan iD, Qian Tong, Yuping Gao, Guoqiang Gu iD und 14 weitere

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.70248 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Tao Chen und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Vascular Calcification, Coronary Artery Disease, Lithotripsy, Cardiac Catheters. Die Arbeit nennt 24 Literaturangaben. Gefördert von: This study was supported by grants from the National Natural Science Foundation of China (No. 82202272 to Dr. Tao Chen, No. 62135002 to Dr. Bo Yu, No. 82202286….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Optimal plaque preparation in calcified coronary lesions is essential to prevent stent failure. Intravascular lithotripsy (IVL) has shown safety and efficacy in treating severe coronary calcification in prior studies. This study aimed to assess the safety and effectiveness of IVL using domestically produced balloons for the treatment of calcified de novo coronary lesions in Chinese patients.

Methods

The VIGOUR trial (NCT05818098) was a prospective, multicenter, single‐arm study designed to obtain approval for coronary IVL in patients with severe coronary calcification. The primary endpoint was procedural success. Secondary endpoints included device success, angiographic success, 30‐day major adverse cardiovascular events (MACE) incidence, and procedure‐related serious complications. An optical coherence tomography (OCT) sub‐study was conducted to assess the mechanisms and predictors of calcium modification.

Results

A total of 189 patients were enrolled. The primary endpoint was achieved in 93.7% of cases, exceeding the performance goal of 87.0% ( p < 0.001). At the secondary endpoints, device success was achieved in 98.9% of patients, and angiographic success in 98.4%. The 30‐day MACE incidence was 5.3%, and procedure‐related serious complication was 0.5%. 81.9% (59/72) of lesions exhibited OCT‐identified multi‐plane and longitudinal calcium fractures after IVL. Multivariable analysis revealed that calcium angle was associated with OCT‐identified calcium fractures.

Conclusions

IVL using domestically produced balloons significantly improves vessel compliance, facilitating successful stent delivery and deployment. This approach proves to be both effective and safe in the Chinese population with severely calcified coronary arteries. OCT‐identified calcium fractures post‐IVL are more likely in calcified lesions with a larger calcium angle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular CalcificationCoronary Artery DiseaseLithotripsyCardiac CathetersAngioplasty, Balloon, CoronaryHumansMaleProspective StudiesFemaleTreatment OutcomeMiddle AgedAgedTime FactorsRisk FactorsCoronary AngiographyChinaSeverity of Illness IndexTomography, Optical CoherenceEquipment Design

Stichwörter der Autor:innen

coronary artery calcificationintravascular lithotripsyoptimal coherence tomography

Autor:innen und Institutionen

  • Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China.
  • The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
  • West China Hospital of Sichuan University, Chengdu, China.
  • Shanxi Cardiovascular Hospital, Taiyuan, China.
  • The People's Hospital of Liaoning Province, Shenyang, China.
  • Xiamen Cardiovascular Hospital Xiamen University, Xiamen, China.

ORCID-Profile: Zuyi Yuan, Guoqiang Gu, Yining Yang, Donghui Zhang, Bo Yu

Förderung

  • This study was supported by grants from the National Natural Science Foundation of China (No. 82202272 to Dr. Tao Chen, No. 62135002 to Dr. Bo Yu, No. 82202286…

Zitieren

APA

Chen, T., Zhao, J., He, Y., Fang, C., Han, X., Luan, B., Wang, Y., Chen, M., Yuan, Z., Tong, Q., Gao, Y., Gu, G., Li, X., Yang, Y., Yu, H., Ma, L., Liu, H., Xu, M., Zhang, D., …, & Yu, B. (2025). Safety and Efficacy of Intravascular Lithotripsy System: A Prospective, Multicenter Clinical Trial (The VIGOUR Study). Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70248

Vancouver

Chen T, Zhao J, He Y, Fang C, Han X, Luan B, et al. Safety and Efficacy of Intravascular Lithotripsy System: A Prospective, Multicenter Clinical Trial (The VIGOUR Study). Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70248

BibTeX
@article{Chen2025,
  author = {Chen, Tao and Zhao, Jiawei and He, Yong and Fang, Chao and Han, Xuebin and Luan, Bo and Wang, Yan and Chen, Manhua and Yuan, Zuyi and Tong, Qian and Gao, Yuping and Gu, Guoqiang and Li, Xiaodong and Yang, Yining and Yu, Huai and Ma, Lijia and Liu, Huimin and Xu, Maoen and Zhang, Donghui and Yang, Guang and Zhang, Shuangyin and Han, Jincheng and Zhang, Maomao and Jia, Haibo and Hou, Jingbo and Yu, Bo},
  title = {Safety and Efficacy of Intravascular Lithotripsy System: A Prospective, Multicenter Clinical Trial (The VIGOUR Study)},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.70248}
}
Kostenlos starten →